CARE Ratings Q4 FY26 profit up 24% YoY, shares jump

Stock reaction: sharp move after earnings

CARE Ratings shares rallied after the company reported strong Q4 FY26 earnings. The stock was up 8.86% to ₹1,748.95 following the results, as investors reacted to higher profit and revenue. Separately, another market update noted CARE Ratings rising 9% to ₹1,465.10 on a day when trading volume hit about 600,000 shares, described as the busiest since October 2024. In an earlier earnings-led move tied to Q4 FY25, the stock was reported up 11% to ₹1,490.60. These sessions highlight how closely the market has been tracking the company’s quarterly profitability and margin performance.

Q4 FY26: PAT, revenue, and PBT all improve

In Q4 FY26, consolidated profit after tax (PAT) rose to ₹52.83 crore, up 23.98% year-on-year from ₹42.61 crore in Q4 FY25. PAT also increased 47.16% sequentially from ₹35.90 crore in Q3 FY26. Revenue from operations grew 19.17% YoY to ₹130.67 crore, compared with ₹109.65 crore in Q4 FY25. On a quarter-on-quarter basis, revenue increased 16.54% from ₹112.12 crore in Q3 FY26. Profit before tax (PBT) came in at ₹72.01 crore, up 22.28% from ₹58.89 crore a year earlier and up 46.99% from ₹48.99 crore in the prior quarter.

Operating performance: EBITDA growth in the quarter

The company’s operating performance also strengthened in Q4 FY26. Consolidated EBITDA was reported at ₹60.76 crore, up 27.91% YoY. The data points to higher profitability alongside revenue growth during the quarter, with PBT and PAT rising faster than the top line on both YoY and QoQ comparisons. While the article does not provide Q4 FY26 margin percentages, the higher EBITDA growth rate versus revenue growth indicates operating leverage during the period.

FY26: full-year growth across revenue and profits

For FY26, consolidated revenue from operations increased 17.59% year-on-year to ₹473.07 crore, compared with ₹402.32 crore in FY25. Full-year PBT rose 22.41% to ₹235.35 crore from ₹192.27 crore. PAT increased 24.73% to ₹171.18 crore from ₹137.24 crore. These numbers show that CARE Ratings delivered faster growth in bottom-line metrics than in revenue for the year, supported by improvement in operating performance and profitability.

Dividend details referenced in the updates

The updates also referred to a final dividend of ₹11 per share and a record date of 27 June 2025 for determining eligible shareholders for the dividend. Another section stated the total dividend declared for the year was ₹18 per share, at a face value of ₹10. Dividend information was highlighted alongside performance commentary, indicating the company linked payout decisions with its reported earnings strength.

Snapshot table: Q4 FY26 compared with prior periods

Additional quarterly context: Q1 FY26 and Q4 FY25 metrics

The article also included quarterly financial snapshots for CARE Ratings Ltd. For Q1 FY26, total income was ₹107.60 crore, with profit before tax of ₹37.44 crore and profit after tax of ₹26.50 crore. Earnings per share (EPS) for Q1 FY26 was ₹8.60. For Q4 FY25, the same dataset showed total income of ₹100.44 crore, PBT of ₹36.19 crore, PAT of ₹24.55 crore, and EPS of ₹8.00. These datasets provide additional context on the company’s quarterly profit trajectory and expense base, though they are presented separately from the Q4 FY26 consolidated performance figures.

Share price performance and the trading range cited

The article cited multi-period performance for CARE Ratings shares: up 39.95% over one year, up 10.98% year-to-date, up 8.66% over six months, up 25.60% over three months, and up 35.65% over one month. A separate price snapshot listed the share price at ₹1,748.9 with open at ₹1,802, previous close ₹1,802.8, day high ₹1,824.1, and day low ₹1,741.2. The 52-week high and low were cited as ₹1,964 and ₹921.8, respectively. The same section stated the price was 10.95% below the 52-week high and 89.73% above the 52-week low.

Company and official commentary referenced

An update attributed comments to Mehul Pandya, Managing Director and Group CEO of Care Edge, stating that in FY25 the company achieved its highest-ever standalone and consolidated income from operations and that performance was supported by contributions from non-ratings businesses and overseas subsidiaries. The same commentary referenced improvements in margins at the consolidated level for FY25, along with better yields from treasury investments supporting other income. While these statements relate to FY25, they were included alongside market moves and earnings coverage, offering context on management’s emphasis on diversification and operating efficiency.

Key takeaways for investors tracking the stock

The Q4 FY26 results showed a clear combination of revenue growth and stronger profitability, with consolidated PAT up nearly 24% YoY and PBT up over 22% YoY. Full-year FY26 performance also reflected sustained profit growth ahead of revenue growth. The stock’s sharp reaction in multiple earnings-linked sessions suggests the market is sensitive to quarterly profit delivery, operating performance, and dividend signals. Investors following the company will likely watch how revenue momentum and profitability trends evolve in subsequent quarters, along with any further disclosures on segment performance and margins.

Conclusion

CARE Ratings’ Q4 FY26 earnings highlighted higher revenue from operations and faster growth in PBT and PAT, and the share price reacted strongly on the day. With FY26 showing double-digit growth across revenue and profits, the next set of quarterly results and any updates on dividends or business mix will remain key checkpoints for market participants.